FDA Approves OTC Device to Help with Urinary Incontinence
Analytica announced that the Food and Drug Administration (FDA) has approved PeriCoach at-home pelvic floor trainer device and smartphone app as an over-the-counter (OTC) treatment for mild, moderate, and stress urinary incontinence (UI) and urge incontinence. PeriCoach was initially launched as a prescription product in 2015.
Pelvic floor muscle training (PFME) is recommended as first-line non-pharmacologic treatment for women who experience urinary incontinence. PeriCoach combines a pelvic floor training sensor that is inserted and squeezed against. The smartphone app guides the user through the training session and monitors progress. The muscle contractions are detected and displayed on the app where results can be shared with a clinician.
PeriCoach will now be available without a prescription starting July 18, 2016. It can be ordered directly at PeriCoach.com.
For more information call (844) 205-0767 or visit PeriCoach.com.